Korean biotechnology firms T&R Biofab and SCM Life Science are to collaborate on the R&D of latest 3D printed tissue regenerative merchandise. The 2 firms will concentrate on marketable cell patch merchandise and new formulations for cell remedy.
“We’re happy to cooperate with T&R Biofab, a pacesetter in 3D bioprinting know-how, to develop new formulations of regenerative medication with stem cells,” mentioned SCM Life Science CEO Rhee Byung-gun. “With this chance, we hope to have the ability to enter the worldwide market.”
Creating 3D printed regenerative tissue merchandise
For over six years T&R Biofab has manufactured 3D printed medical transplantation and tissue regenerative units to be used in orthopedics, cosmetic surgery, and dentistry. Its 3D bioprinters had been developed and manufactured utilizing the corporate’s personal know-how, and might 3D print numerous biomaterials, together with deCelluid™ (hydrogel tissue-derived bioink), artificial and biodegradable polymers, and ceramics.
In April 2019 T&R Biofab registered a patent for its 3D bioprinting know-how to create synthetic pores and skin. The know-how operates by means of the 3D printing of dermal (interior layers of pores and skin) and epidermal (outer layers of pores and skin) cells that makes use of a porous 3D construction to type pores and skin with related traits to precise tissue.
3D printing mesenchymal stem cells
The brand new partnership will mix T&R Biofab’s printing platform with SCM Life Science’s high-purity mesenchymal stem cell know-how.
Mesenchymal stem cells, or grownup stem cells, can remodel into a wide range of cell varieties, together with bone cells, cartilage cells, muscle cells and fats cells. SCM’s collaboration with T&R plans to make use of these stem cells to create regenerative tissue and deal with immunological situations.
T&R Biofab may also acquire entry to bio-ink materials appropriate for tissue fabrication, good manufacturing apply (GMP)-based cell manufacturing system and good laboratory apply (GLP)-based security analysis system.
T&R Biofab CEO Yun Gained-soo mentioned, “The corporate expects that will probably be in a position to speed up the launch of 3D bioprinting cell remedy merchandise by means of cooperation with SCM Life Science, which has distinctive mesenchymal stem cell know-how and GMP manufacturing services.”
A 3D printed customized scaffold, printed utilizing T&R Biofab’s bioprinter. Picture by way of T&R Biofab.
Subscribe to the 3D Printing Business e-newsletter and observe us on Fb and Twitter for the newest information in additive manufacturing.
Go to our 3D Printing Jobs board to seek out new alternatives in your trade.
Featured picture exhibits a prototype organ 3D printed utilizing T&R Biofab’s bioprinter. Picture by way of T&R Biofab.
Credit score : Supply Hyperlink